Formulation optimization and characterization of spray dried microparticles for inhalation delivery of doxycycline hyclate.

The local delivery of antibiotics in the treatment of infectious respiratory diseases is an attractive alternative to deliver high concentration of antimicrobials directly to the lungs and minimize systemic side effects. In this study, inhalable microparticles containing doxycycline hyclate, sodium carboxymethylcellulose, leucine and lactose were prepared by spray drying of aqueous ethanol formulations. Box-Behnken design was used to study the influence of various independent variables such as polymer concentration, leucine concentration, ethanol concentration and inlet temperature of the spray dryer on microparticle characteristics. The microparticles were characterized in terms of particle morphology, drug excipient interaction, yield, entrapment efficiency, Carr's index, moisture content, thermal properties, X-ray powder diffraction, aerosolization performance and in vitro drug release. The effect of independent variables on spray dryer outlet temperature was also studied. The overall shape of the particles was found to be spherical like doughnuts in the size range of 1.16-5.2 µm. The optimized formulation (sodium carboxymethylcellulose concentration 14% w/v, leucine concentration 33% w/v, ethanol concentration 36% v/v, inlet temperature of 140°C) exhibited the following properties: yield 56.69%, moisture content 3.86%, encapsulation efficiency 61.74%, theoretical aerodynamic diameter 3.11 µm and Carr's index 23.5% at an outlet temperature 77°C. The powders generated were of a suitable mass median aerodynamic diameter (4.89 µm) with 49.3% fine particle fraction and exhibited a sustained drug release profile in vitro.

[1]  B. Mishra,et al.  Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery , 2011, Journal of drug targeting.

[2]  P. Seville,et al.  Novel pMDI formulations for pulmonary delivery of proteins. , 2010, International journal of pharmaceutics.

[3]  Lei Wang,et al.  Characterization of a new inhalable thymopentin formulation. , 2009, International journal of pharmaceutics.

[4]  H. Okada,et al.  One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[5]  H. Chan,et al.  Cospray dried antibiotics for dry powder lung delivery. , 2008, Journal of pharmaceutical sciences.

[6]  P. Seville,et al.  Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Reinhard Vehring,et al.  Pharmaceutical Particle Engineering via Spray Drying , 2007, Pharmaceutical Research.

[8]  J. Kaur,et al.  Inhalable microparticles containing large payload of anti-tuberculosis drugs. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  B. Padhi,et al.  Development of dry powder inhalers. , 2007, Recent patents on drug delivery & formulation.

[10]  H. Chan Dry powder aerosol drug delivery- : Opportunities for colloid and surface scientists , 2006 .

[11]  P. Young,et al.  Novel Temperature Controlled Surface Dissolution of Excipient Particles for Carrier Based Dry Powder Inhaler Formulations , 2006, Drug development and industrial pharmacy.

[12]  J. Staniforth,et al.  Active and intelligent inhaler device development. , 2004, International journal of pharmaceutics.

[13]  V. Préat,et al.  Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[14]  B. Strauss,et al.  Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. , 2002, The American journal of pathology.

[15]  M. Macka,et al.  The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  Y. Makino,et al.  Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[17]  V. Préat,et al.  Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  John N. Staniforth,et al.  Enhancement of Small Particle Size Dry Powder Aerosol Formulations using an Ultra Low Density Additive , 1999, Pharmaceutical Research.

[19]  G. Wood,et al.  Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia , 2012, Drugs.